{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:30:23Z","timestamp":1771666223331,"version":"3.50.1"},"reference-count":69,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3744,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1196\/annals.1361.086","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T20:08:07Z","timestamp":1125086887000},"page":"442-454","source":"Crossref","is-referenced-by-count":30,"title":["The Role of Innate and Adaptive Immunity to Oxidized Low-Density Lipoprotein in the Development of Atherosclerosis"],"prefix":"10.1111","volume":"1051","author":[{"given":"KAZUKO","family":"KOBAYASHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUIS R.","family":"LOPEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YEHUDA","family":"SHOENFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EIJI","family":"MATSUURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1196\/annals.1361.086-BIB1","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","article-title":"Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids","volume":"81","author":"Steinbrecher","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1196\/annals.1361.086-BIB2","first-page":"915","article-title":"Beyond cholesterol","volume":"320","author":"Steinberg","year":"1989","journal-title":"Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med."},{"key":"10.1196\/annals.1361.086-BIB3","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1196\/annals.1361.086-BIB4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.15.5.704","article-title":"Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins","volume":"15","author":"Hammer","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB5","first-page":"605","article-title":"ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis","volume":"14","author":"Palinski","year":"1994","journal-title":"Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb."},{"key":"10.1196\/annals.1361.086-BIB6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidis ed LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.086-BIB7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1196\/annals.1361.086-BIB8","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1196\/annals.1361.086-BIB9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.086-BIB10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.086-BIB11","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.4049\/jimmunol.148.12.3885","article-title":"Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor","volume":"148","author":"Matsuura","year":"1992","journal-title":"J. Immunol."},{"key":"10.1196\/annals.1361.086-BIB12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize \u03b22-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1196\/annals.1361.086-BIB13","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of \u03b22-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.086-BIB14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.086-BIB15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/37.7.746","article-title":"Lack of cross-reaction between antibodies to \u03b22-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome","volume":"37","author":"Tinahones","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1196\/annals.1361.086-BIB16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/37.8.883","article-title":"Arterial disease in lupus and secondary antiphospholipid syndrome: a ssociation with anti-\u03b22-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein","volume":"37","author":"Romero","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1196\/annals.1361.086-BIB17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M200329-JLR200","article-title":"Circulating oxidized LDL forms complexes with \u03b22-glycoprotein I: implication as an atherogenic autoantigen","volume":"44","author":"Kobayashi","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1196\/annals.1361.086-BIB18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2249.1997.d01-948.x","article-title":"Involvement of \u03b22-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages","volume":"107","author":"Hasunuma","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.086-BIB19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2275(20)31631-X","article-title":"A specific ligand for \u03b22-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages","volume":"42","author":"Kobayashi","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1196\/annals.1361.086-BIB20","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M20063-JLR200","article-title":"w-carboxyl variants of 7-ketocholesteryl esters are ligands for \u03b22-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages","volume":"43","author":"Liu","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1196\/annals.1361.086-BIB21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat. Med."},{"key":"10.1196\/annals.1361.086-BIB22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/clim.2002.5269","article-title":"Pro-atherogenic and pro-inflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL","volume":"105","author":"Virella","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.086-BIB23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","article-title":"The role of oxidized lipoproteins in atherogenesis","volume":"20","author":"Berliner","year":"1996","journal-title":"Free Radical Biol. & Med."},{"key":"10.1196\/annals.1361.086-BIB24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1172\/JCI116605","article-title":"Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes","volume":"92","author":"McMurray","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.086-BIB25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"85","author":"Yla-Herttuala","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.086-BIB26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/096120339600500522","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"5","author":"Vaarala","year":"1996","journal-title":"Lupus"},{"key":"10.1196\/annals.1361.086-BIB27","doi-asserted-by":"crossref","unstructured":"27Palinski, W., S. Horkko, E. Miller, et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98: 800- 814.","DOI":"10.1172\/JCI118853"},{"key":"10.1196\/annals.1361.086-BIB28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","article-title":"Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity","volume":"105","author":"Shaw","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.086-BIB29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.086-BIB30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.ATV.21.1.108","article-title":"LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis","volume":"21","author":"Zhou","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI7272","article-title":"Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice","volume":"109","author":"Caligiuri","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.086-BIB32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00015-X","article-title":"Hyperimmunization of apo-E deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis","volume":"138","author":"George","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1196\/annals.1361.086-BIB33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/jaut.2000.0393","article-title":"Heat shock protein 60\/50, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis","volume":"15","author":"Shoenfeld","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1196\/annals.1361.086-BIB34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol. Med."},{"key":"10.1196\/annals.1361.086-BIB35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1203\/00006450-199901000-00016","article-title":"Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children","volume":"45","author":"Iughetti","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1196\/annals.1361.086-BIB36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02592290","article-title":"Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers","volume":"23","author":"Virella","year":"1993","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1196\/annals.1361.086-BIB37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.HYP.33.1.53","article-title":"Autoantibodies to oxLDL are decreased in individuals with borderline hypertension","volume":"33","author":"Wu","year":"1999","journal-title":"Hypertension"},{"key":"10.1196\/annals.1361.086-BIB38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/clim.1998.4631","article-title":"Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus","volume":"90","author":"Lopes-Virella","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.086-BIB39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(99)00218-X","article-title":"Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects","volume":"148","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1196\/annals.1361.086-BIB40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.ATV.20.3.703","article-title":"Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population","volume":"20","author":"Fukumoto","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/CS20030152","article-title":"Circulating oxidized low-density lipoprotein is increased in hypertension","volume":"105","author":"Frostegard","year":"2003","journal-title":"Clin. Sci."},{"key":"10.1196\/annals.1361.086-BIB42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yla-Herttuala","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1196\/annals.1361.086-BIB43","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1161\/01.ATV.17.11.3159","article-title":"Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction","volume":"17","author":"Wu","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB44","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.1994.00420220105012","article-title":"Antibody against oxidized low-density lipoprotein predicting myocardial infarction","volume":"154","author":"Puurunen","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1196\/annals.1361.086-BIB45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/clc.4960230616","article-title":"The prediction of coronary atherosclerosis employing artificial neural networks","volume":"23","author":"George","year":"2000","journal-title":"Clin. Cardiol."},{"key":"10.1196\/annals.1361.086-BIB46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0165-2478(99)00050-4","article-title":"Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty","volume":"68","author":"George","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1196\/annals.1361.086-BIB47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.15.4.441","article-title":"Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL","volume":"15","author":"Bergmark","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1196\/annals.1361.086-BIB49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1995.tb06652.x","article-title":"Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotope, subclass, affinity and effect on the macrophage uptake of oxLDL","volume":"102","author":"Wu","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.086-BIB50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/clim.2002.5269","article-title":"Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL","volume":"105","author":"Virella","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.086-BIB51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.ATV.16.2.222","article-title":"Isolation and characterization of human antioxidized LDL autoantibodies","volume":"16","author":"Mironova","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1196\/annals.1361.086-BIB52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/0891693031000080228","article-title":"Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations-possible immunomodulation of atherosclerosis","volume":"36","author":"Wu","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1196\/annals.1361.086-BIB53","first-page":"1073","article-title":"A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers","volume":"27","author":"Devey","year":"1974","journal-title":"Immunology"},{"key":"10.1196\/annals.1361.086-BIB54","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.78.10.6499","article-title":"Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins","volume":"78","author":"Henriksen","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1196\/annals.1361.086-BIB55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2249.1999.00830.x","article-title":"Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus","volume":"115","author":"Wu","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.086-BIB56","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/1RYQ-Q2AJ-CKF7-YCDE","article-title":"Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis","volume":"116","author":"Zhao","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1196\/annals.1361.086-BIB57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/41.9.988","article-title":"Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis","volume":"41","author":"Cvetkovic","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1196\/annals.1361.086-BIB58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1191\/096120399678847434","article-title":"Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE","volume":"8","author":"Wu","year":"1999","journal-title":"Lupus"},{"key":"10.1196\/annals.1361.086-BIB59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2249.1999.00830.x","article-title":"Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus","volume":"115","author":"Wu","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.086-BIB60","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1191\/096120301667475689","article-title":"Anti-oxidized low-density- lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome","volume":"10","author":"Hayem","year":"2001","journal-title":"Lupus"},{"key":"10.1196\/annals.1361.086-BIB61","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2337\/diabetes.48.7.1454","article-title":"Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes","volume":"48","author":"Orchard","year":"1999","journal-title":"Diabetes"},{"key":"10.1196\/annals.1361.086-BIB62","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","article-title":"Adhesion mechanism of human \u03b22-glycoprotein I to phospholipids based on its crystal structure","volume":"18","author":"Bouma","year":"1999","journal-title":"EMBO J."},{"key":"10.1196\/annals.1361.086-BIB63","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1006\/jmbi.2000.4243","article-title":"Identification of the phospholipid-binding site of human \u03b22-glycoprotein I domain V by heteronuclear magnetic resonance","volume":"304","author":"Hoshino","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1196\/annals.1361.086-BIB64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/36.12.1247","article-title":"\u03b22-glycoprotein I and anti-\u03b22-glycoprotein I antibodies: where are we now? Br","volume":"36","author":"Inanc","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1196\/annals.1361.086-BIB65","first-page":"S5","article-title":"\u03b22-glycoprotein I: target antigen for \u2018antiphospholipid\u2019 antibodies","volume":"7","author":"Sheng","year":"1998","journal-title":"Immunological and molecular aspects. Lupus"},{"key":"10.1196\/annals.1361.086-BIB66","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0037-1614566","article-title":"Enhancement of protein S anticoagulant function by \u03b22-glycoprotein I, a major target antigen of antiphospholipid antibodies: \u03b22-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4\u03b2-binding protein","volume":"81","author":"Merrill","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1196\/annals.1361.086-BIB67","first-page":"1063","article-title":"Anticardiolipin antibodies in NZW x BXSB F1 mice","volume":"149","author":"Hashimoto","year":"1992","journal-title":"A model of antiphospholipid syndrome. J. Immunol."},{"key":"10.1196\/annals.1361.086-BIB68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/2AUE6HD4W6TLEUU5","article-title":"Oxidized low-density lipoprotein\/\u03b22-glycoprotein I complexes and autoantibodies to oxLig-1\/\u03b22-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"121","author":"Lopez","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1196\/annals.1361.086-BIB69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10446670310001642113","article-title":"IgG Autoantibodies against b2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome","volume":"10","author":"Lopez","year":"2003","journal-title":"Clin. Dev. Immunol."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1361.086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1196\/annals.1361.086\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T08:44:39Z","timestamp":1706517879000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1196\/annals.1361.086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1196\/annals.1361.086","relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}